ATE209657T1 - Organometallische komplexe von sterin verbindungen und glykosiden und pharmazeutische zusammensetzungen und diätetische produkte davon - Google Patents
Organometallische komplexe von sterin verbindungen und glykosiden und pharmazeutische zusammensetzungen und diätetische produkte davonInfo
- Publication number
- ATE209657T1 ATE209657T1 AT97930606T AT97930606T ATE209657T1 AT E209657 T1 ATE209657 T1 AT E209657T1 AT 97930606 T AT97930606 T AT 97930606T AT 97930606 T AT97930606 T AT 97930606T AT E209657 T1 ATE209657 T1 AT E209657T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- relates
- pharmaceutical compositions
- insulin
- sec
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- -1 STEROL COMPOUNDS Chemical class 0.000 title 1
- 229930182558 Sterol Natural products 0.000 title 1
- 235000005911 diet Nutrition 0.000 title 1
- 230000000378 dietary effect Effects 0.000 title 1
- 229930182470 glycoside Natural products 0.000 title 1
- 150000002338 glycosides Chemical class 0.000 title 1
- 235000003702 sterols Nutrition 0.000 title 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 abstract 3
- VGSSUFQMXBFFTM-UHFFFAOYSA-N (24R)-24-ethyl-5alpha-cholestane-3beta,5,6beta-triol Natural products C1C(O)C2(O)CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 VGSSUFQMXBFFTM-UHFFFAOYSA-N 0.000 abstract 2
- LGJMUZUPVCAVPU-JFBKYFIKSA-N Sitostanol Natural products O[C@@H]1C[C@H]2[C@@](C)([C@@H]3[C@@H]([C@H]4[C@@](C)([C@@H]([C@@H](CC[C@H](C(C)C)CC)C)CC4)CC3)CC2)CC1 LGJMUZUPVCAVPU-JFBKYFIKSA-N 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 229910052751 metal Inorganic materials 0.000 abstract 2
- 239000002184 metal Substances 0.000 abstract 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 abstract 2
- LGJMUZUPVCAVPU-HRJGVYIJSA-N stigmastanol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]2(C)CC1 LGJMUZUPVCAVPU-HRJGVYIJSA-N 0.000 abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 abstract 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 abstract 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 abstract 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 abstract 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 abstract 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 abstract 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 abstract 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000005642 Oleic acid Substances 0.000 abstract 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 abstract 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 abstract 1
- 239000011942 biocatalyst Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 208000006575 hypertriglyceridemia Diseases 0.000 abstract 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000002524 organometallic group Chemical group 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000000419 plant extract Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 150000004671 saturated fatty acids Chemical class 0.000 abstract 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 abstract 1
- 229950005143 sitosterol Drugs 0.000 abstract 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 abstract 1
- 235000015500 sitosterol Nutrition 0.000 abstract 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract 1
- 229910052720 vanadium Inorganic materials 0.000 abstract 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9608263A FR2750606B1 (fr) | 1996-07-03 | 1996-07-03 | Complexes organometalliques a base de sitosterols et de diglycerides et compositions pharmaceutiques en contenant |
| PCT/FR1997/001153 WO1998001461A1 (fr) | 1996-07-03 | 1997-06-27 | Complexes organo-metalliques a base de sterols et de diglycerides et compositions pharmaceutiques et produits dietetiques en contenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE209657T1 true ATE209657T1 (de) | 2001-12-15 |
Family
ID=9493663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97930606T ATE209657T1 (de) | 1996-07-03 | 1997-06-27 | Organometallische komplexe von sterin verbindungen und glykosiden und pharmazeutische zusammensetzungen und diätetische produkte davon |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6129924A (de) |
| EP (1) | EP0912599B1 (de) |
| AT (1) | ATE209657T1 (de) |
| AU (1) | AU3449397A (de) |
| CA (1) | CA2295867C (de) |
| DE (1) | DE69708643T2 (de) |
| ES (1) | ES2170401T3 (de) |
| FR (1) | FR2750606B1 (de) |
| WO (1) | WO1998001461A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1195420C (zh) * | 1998-03-24 | 2005-04-06 | 花王株式会社 | 油脂加工食品 |
| US6025348A (en) * | 1998-04-30 | 2000-02-15 | Kao Corporation | Oil and fat composition containing phytosterol |
| US6890568B2 (en) * | 1999-05-24 | 2005-05-10 | Grant Pierce | Method for management of blood glucose levels |
| JP3779505B2 (ja) | 1999-08-24 | 2006-05-31 | 花王株式会社 | 油脂組成物 |
| US20030044846A1 (en) * | 2001-04-03 | 2003-03-06 | Gary Eldridge | Screening of chemical compounds purified from biological sources |
| AU2001246876A1 (en) * | 2000-04-10 | 2001-10-23 | Takara Bio Inc. | Remedies |
| US7416749B2 (en) * | 2000-06-12 | 2008-08-26 | Access Business Group International Llc | Dietary supplement and related method |
| US7438936B2 (en) * | 2000-06-12 | 2008-10-21 | Access Business Group International Llc | Dietary supplement and related method |
| DE60132523T2 (de) * | 2000-08-03 | 2008-04-30 | Härting, Thomas Francis | Pharmazeutische- und Nahrungsmittelzusammensetzungen mit "Holzalkohol" und "Holzsterol" zur Senkung des Serumcholesterins |
| GB2368521B (en) * | 2000-10-31 | 2004-12-08 | Jasali Ltd | Pharmaceutical or dietary composition containing a vegetable oil in particular olive oil and sitosterol |
| BRPI0106382B1 (pt) * | 2001-03-13 | 2017-07-11 | Universidade Do Estado Do Rio De Janeiro - Uerj | Process for obtaining decocts from vitis labrusca and vitis vinifera casts, process for obtaining the hydro-alcoholic extract, process for obtaining the hydro-alcoholic extract-ethyl acetate and pharmaceutical compositions |
| US6793946B2 (en) | 2002-07-31 | 2004-09-21 | Access Business Group International Llc. | Composition and method for lowering cholesterol |
| US20060034949A1 (en) * | 2002-08-09 | 2006-02-16 | Tatsuji Enoki | Remedy |
| IL155136A0 (en) * | 2003-02-10 | 2003-10-31 | Enzymotec Ltd | A composition for reducing blood cholesterol and triglycerides |
| US20060233863A1 (en) * | 2003-02-10 | 2006-10-19 | Enzymotec Ltd. | Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy |
| EP1452175A1 (de) * | 2003-02-28 | 2004-09-01 | Medesis Pharma S.A. | Organometallische Komplexe entahltend Mangan, pharmazeutische Formulierungen und Diätetika |
| JP4098276B2 (ja) * | 2003-06-16 | 2008-06-11 | 花王株式会社 | 酸性水中油型乳化組成物 |
| US20050063990A1 (en) * | 2003-09-18 | 2005-03-24 | Keller Robert H. | Compositons and methods for weight loss |
| FR2862224A1 (fr) * | 2003-11-14 | 2005-05-20 | Medesis Pharma Sa | Complexes a base de strontium, pharmaceutiques et produits dietetiques |
| CN101035594B (zh) * | 2004-08-09 | 2013-10-23 | 酶学技术有限公司 | 用于糖尿病患者的食品 |
| RU2394576C2 (ru) | 2004-08-10 | 2010-07-20 | Энзимотек Лтд. | Способы лечения, требующие фитокомпонентов |
| TWI363600B (en) * | 2004-09-21 | 2012-05-11 | Kao Corp | Acidic oil-in-water emulsion composition |
| US7799937B2 (en) | 2004-10-25 | 2010-09-21 | Synthonics, Inc. | Metal coordinated compositions |
| US20060141054A1 (en) * | 2004-10-25 | 2006-06-29 | Thomas Piccariello | Metal coordinated compositions |
| US8779175B2 (en) | 2004-10-25 | 2014-07-15 | Synthonics, Inc. | Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients |
| EP1652512A1 (de) * | 2004-11-02 | 2006-05-03 | Medesis Pharma | Umkehrmizellen-Zusammensetzung zur Verabreichung von Metallkationen enthaltend einen Diglycerid und einen Phytosterol und Verfahren zur Herstellung |
| EP1652513A1 (de) * | 2004-11-02 | 2006-05-03 | Denderah Pharm Sa | Reverse Mizellen auf der Basis von Sterolen und Acylglycerolen und ihre therapeutischen Verwendungen |
| US8231913B2 (en) * | 2005-11-10 | 2012-07-31 | Jose Angel Olalde Rangel | Angina pectoris and ischemic heart disease and synergistic phytoceutical composition for same |
| US7303772B2 (en) * | 2005-11-10 | 2007-12-04 | Olalde Rangel Jose Angel | Synergistic phytoceutical compositions |
| EP2488045A4 (de) * | 2009-08-11 | 2013-02-20 | Phytochem Pharmaceuticals | Verfahren zur herstellung von olivenöl mit niedrigem triglyceridgehalt und neuen fraktionen |
| PT2550020E (pt) | 2010-03-24 | 2015-10-20 | Medesis Pharma | Microemulsão de micelas reversas compreendendo iões metálicos e sua utilização |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4195094A (en) * | 1977-12-23 | 1980-03-25 | Research Corporation | Zinc containing hypoglycemic agents |
| FR2686515B1 (fr) * | 1992-01-28 | 1994-04-29 | Ir2M | Utilisation des derives du niobium comme principe actif de medicaments utiles dans le traitement et/ou la prevention des desordres du metabolisme des glucides et/ou des lipides. |
| FR2686511B1 (fr) * | 1992-01-28 | 1995-06-23 | Ir2M | Composition pharmaceutique contenant des associations de vanadium et/ou de niobium avec des acides amines ou des derives d'acides amines. |
| FR2686514B1 (fr) * | 1992-01-28 | 1994-05-20 | Ir2M | Composition pharmaceutique contenant comme principe actif des associations de vanadium et/ou de niobium avec des composes organiques contenant un cycle renfermant au moins deux atomes d'azote. |
| FR2686512B1 (fr) * | 1992-01-28 | 1995-06-30 | Ir2M | Compositions pharmaceutiques contenant comme principe actif des associations de vanadium et/ou de niobium avec des derives du pyrocatechol. |
| US5244887A (en) * | 1992-02-14 | 1993-09-14 | Straub Carl D | Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof |
| FR2729957B1 (fr) * | 1995-01-31 | 1997-12-05 | Maurel Sante | Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant. |
-
1996
- 1996-07-03 FR FR9608263A patent/FR2750606B1/fr not_active Expired - Fee Related
-
1997
- 1997-06-27 CA CA002295867A patent/CA2295867C/fr not_active Expired - Fee Related
- 1997-06-27 DE DE69708643T patent/DE69708643T2/de not_active Expired - Lifetime
- 1997-06-27 AT AT97930606T patent/ATE209657T1/de active
- 1997-06-27 EP EP97930606A patent/EP0912599B1/de not_active Expired - Lifetime
- 1997-06-27 AU AU34493/97A patent/AU3449397A/en not_active Abandoned
- 1997-06-27 ES ES97930606T patent/ES2170401T3/es not_active Expired - Lifetime
- 1997-06-27 WO PCT/FR1997/001153 patent/WO1998001461A1/fr not_active Ceased
- 1997-06-30 US US08/945,761 patent/US6129924A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6129924A (en) | 2000-10-10 |
| CA2295867A1 (fr) | 1998-01-15 |
| DE69708643T2 (de) | 2002-08-01 |
| CA2295867C (fr) | 2006-11-21 |
| EP0912599B1 (de) | 2001-11-28 |
| EP0912599A1 (de) | 1999-05-06 |
| FR2750606B1 (fr) | 1999-01-29 |
| WO1998001461A1 (fr) | 1998-01-15 |
| DE69708643D1 (de) | 2002-01-10 |
| AU3449397A (en) | 1998-02-02 |
| ES2170401T3 (es) | 2002-08-01 |
| FR2750606A1 (fr) | 1998-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE209657T1 (de) | Organometallische komplexe von sterin verbindungen und glykosiden und pharmazeutische zusammensetzungen und diätetische produkte davon | |
| DE60208544T2 (de) | Natürliche phenolische produkte und deren derivate zum schutz vor neurodegenerativen erkrankungen | |
| Caldwell et al. | Interrelationships between xenobiotic metabolism and lipid biosynthesis | |
| GEP20022788B (en) | Pharmaceutical Compositions Having Appetite Suppressant Activity | |
| DK0515460T4 (da) | Docosahexaensyre, fremgangsmåder til fremstilling deraf og forbindelser indeholdende samme | |
| AU561811B2 (en) | Organic amide compounds derived from nitrogenous lipids | |
| NZ508578A (en) | Fatty acid esters of phytosterol or phytostanol containing compositions useful in food products | |
| YU76503A (sh) | Farmaceutski aktivni estri uridina | |
| TR200504156T2 (tr) | Psikiyatrik ve nörolojik bozukluklar için yüksek ölçüde saflaştırılmış etil EPA ve diğer EPA türevleri. | |
| GB9906914D0 (en) | Compositions containing boswellia extracts | |
| JPS63218649A (ja) | 抗酸化性アミノ酸系物質並びに該物質を主成分とする抗酸化剤 | |
| BE904757A (fr) | Esters gras bi-ou tri-eniques d'erythromycine a, leur procede de preparation et compositons pharmaceutiques et cosmetiques les contenant. | |
| DE3909707A1 (de) | Arzneimittel, geeignet zur einwirkung auf herz und kreislauf | |
| EP0271909A2 (de) | Triglycerid enthaltende Zusammensetzung | |
| FR2722410B1 (fr) | Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique | |
| Schmidt et al. | The effect of therapeutic agents on the volume and the constituents of bile | |
| NZ333985A (en) | An oligosaccharide and its use in a dermatocosmetic composition | |
| FR2671725B1 (fr) | Complexe de polyose et d'acide gras, utilisation comme agent emulsionnant ou hydratant et composition emulsionnante ou hydratante en contenant. | |
| CA2217258A1 (en) | Triglycerides | |
| ATE161527T1 (de) | Methode zur solubilisierung organischer verbindungen in lipophilen systemen ,neue chemische komplexe solcher verbindungen und verschiedene anwendungen dieser komplexe | |
| ATE352308T1 (de) | Komplexe auf strontiumbasis, pharmazeutische zusammensetzungen und dietätische produkte | |
| Ward et al. | Hydroxylation of steroids by the isolated rat adrenal | |
| DE69330165D1 (en) | Bioaktive triterpenoide und sec0-triterpenoide | |
| JP2831395B2 (ja) | アスコルビン酸エステル | |
| Papp et al. | Multiple Deuteration of Water-Soluble Olefinic Acids with a [Pd (Alizarin Monosulfonate) 2] Catalyst |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |